Olivier Rouaud

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


134 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2002 |
 
Diabetes mellitus in older persons with neurocognitive disorder: overtreatment prevalence and associated structural brain MRI findings.
Putallaz P., Seematter-Bagnoud L., Draganski B., Rouaud O., Krief H., Büla C.J., 2024/05/14. BMC geriatrics, 24 (1) p. 427. Peer-reviewed.
Reader Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.
Chiabotti P.S., Rouaud O., Allali G., 2024/05/14. Neurology, 102 (9) pp. e209375. Peer-reviewed.
 
Neurologie: ce qui a changé en 2023 [Neurology: what's new in 2023]
Pizzarotti B., Buhler-Heintze A., Allali G., Rouaud O., Bally J., Michel P., Hirt L., Théaudin M., Pot Kreis C., Ryvlin P. et al., 2024/01/17. Revue medicale suisse, 20 (856-7) pp. 72-75. Peer-reviewed.
 
Amnestic Syndrome in Memory Clinics: Similar Morphological Brain Patterns in Older Adults with and without Alzheimer's Disease.
Lalive H.M., Griffa A., Carlier S., Nasuti M., Di Noto T., Maréchal B., Rouaud O., Allali G., 2024. Journal of Alzheimer's disease, 100 (1) pp. 333-343. Peer-reviewed.
Circulating Biomarkers for Alzheimer's Disease: Unlocking the Diagnostic Potential in Low- and Middle-Income Countries, Focusing on Africa.
Nwamekang Belinga L., Espourteille J., Wepnyu Njamnshi Y., Zafack Zeukang A., Rouaud O., Kongnyu Njamnshi A., Allali G., Richetin K., 2024. Neuro-degenerative diseases, 24 (1) pp. 26-40. Peer-reviewed.
Antidepressants and the risk of bleeding in the era of anti-amyloid drugs.
Pozuelo Moyano B., Salvioni P., Zullo L., Rouaud O., von Gunten A., Girardin F.R., Allali G., 2023/12. Alzheimer's & dementia, 19 (12) pp. 5847-5848. Peer-reviewed.
Don't forget primary progressive aphasia for anti-amyloid drugs: An estimation of eligible patients from the Lausanne Memory Center registry.
Hausmann A., Chiabotti P.S., Nasuti M., Rouaud O., Allali G., 2023/11. Alzheimer's & dementia, 19 (11) pp. 5303-5304. Peer-reviewed.
Approche graduelle pour le diagnostic étiologique des troubles neurocognitifs [Gradual approach for the etiological diagnosis of the neurocognitive disorder]
Knüsel D., Rouaud O., Renard D., Brovedani E., Lievens L., Daher O., 2023/06/14. Revue medicale suisse, 19 (831) pp. 1200-1205. Peer-reviewed.
The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with Lewy bodies: an updated systematic review.
Jreige M., Kurian G.K., Perriraz J., Potheegadoo J., Bernasconi F., Stampacchia S., Blanke O., Alessandra G., Lejay N., Chiabotti P.S. et al., 2023/06. European journal of nuclear medicine and molecular imaging, 50 (7) pp. 1988-2035. Peer-reviewed.
Neurologie : ce qui a changé en 2022 [Neurology: what's new in 2022]
Bouvy C., Caranzano L., Allali G., Bally J., Benninger D., Beuchat I., Castro Jimenez M., Di Virgilio G., Hirt L., Michel P. et al., 2023/01/18. Revue medicale suisse, 19 (809-10) pp. 42-45. Peer-reviewed.
Alzheimer's early detection in post-acute COVID-19 syndrome: a systematic review and expert consensus on preclinical assessments.
Vandersteen C., Plonka A., Manera V., Sawchuk K., Lafontaine C., Galery K., Rouaud O., Bengaied N., Launay C., Guérin O. et al., 2023. Frontiers in aging neuroscience, 15 p. 1206123. Peer-reviewed.
Ataxie cérébelleuse subaiguë : une atteinte atypique par le SARS-CoV-2 chez la personne âgée [Subacute cerebellar ataxia, an uncommon SARS-CoV-2 complication infection in older adults]
Perret T., Major K., Bosshard W., Büla C., Rouaud O., 2022/11/02. Revue medicale suisse, 18 (802) pp. 2053-2056. Peer-reviewed.
Troubles neurocognitifs d’évolution rapide [Fast-evolving cognitive impairment: a home-based diagnosis]
Barbarossa L., Gagliano M., Major K., Rouaud O., Büla C., 2022/11/02. Revue medicale suisse, 18 (802) pp. 2071-2075. Peer-reviewed.
 
Transient global amnesia with unexpected clinical and radiological findings: A case series and systematic review.
Piffer S., Nannoni S., Maulucci F., Beaud V., Rouaud O., Förster A., Cereda C.W., Maeder P., Michel P., 2022/10/15. Journal of the neurological sciences, 441 p. 120349. Peer-reviewed.
 
Acute neurological disease as a trigger or co-occurrence of transient global amnesia: a case series and systematic review.
Piffer S., Nannoni S., Maulucci F., Beaud V., Rouaud O., Cereda C.W., Maeder P., Michel P., 2022/10. Neurological sciences, 43 (10) pp. 5959-5967. Peer-reviewed.
Neurologie [Neurology : what's new in 2021]
Vicino A., Allali G., Bally J., Castro Jimenez M., Chiabotti Salvioni P., Hirt L., Hottinger A., Michel P., Novy J., Pot Kreis C. et al., 2022/01/19. Revue medicale suisse, 18 (764-5) pp. 51-55. Peer-reviewed.
 
Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey.
Frederiksen K.S., Nielsen T.R., Appollonio I., Andersen B.B., Riverol M., Boada M., Ceccaldi M., Dubois B., Engelborghs S., Frölich L. et al., 2021/02. International journal of geriatric psychiatry, 36 (2) pp. 324-333. Peer-reviewed.
Aptitude cognitive à la conduite automobile : retour d’expérience du Centre Leenaards de la Mémoire [Cognitive fitness to drive : feedback at Leenaards Memory Centre]
Carlier S., Demonet J.F., Rouaud O., 2021/01/27. Revue medicale suisse, 17 (723) pp. 225-229. Peer-reviewed.
Neurologie [Recent Advances in Neurology]
Anichini A., Salvioni Chiabotti P., Bally J., Castro Jimenez M., Démonet J.F., Di Virgilio G., Hirt L., Hottinger A., Kuntzer T., Michel P. et al., 2021/01/27. Revue medicale suisse, 17 (723) pp. 196-200. Peer-reviewed.
Improving the Diagnosis of the Frontal Variant of Alzheimer's Disease with the DAPHNE Scale.
Lehingue E., Gueniat J., Jourdaa S., Hardouin J.B., Pallardy A., Courtemanche H., Rocher L., Etcharry-Bouyx F., Auriacombe S., Mollion H. et al., 2021. Journal of Alzheimer's disease, 79 (4) pp. 1735-1745. Peer-reviewed.
Troubles neurocognitifs chez les personnes âgées avec maladie oncologique [Cancer-related cognitive impairment in older adults]
Baratali L., Major K., Rouaud O., Draganski B., 2020/11/11. Revue medicale suisse, 16 (714) pp. 2172-2175. Peer-reviewed.
 
Teleneuropsychology: New technologies and assessment tools
Genoud-Prachex Thomas, Perrenoud Matthieu Paul, Brioschi Guevara Andrea, Bieler-Aeschlimann Mélanie, Moser Charlène, rouaud Olivier, Démonet jean-François, 2020/10/01. Revue de neuropsychologie.
 
Unsuspected Alzheimer disease in a patient with Multiple sclerosis and progressive aphasia.
Borrelli S., Genoud-Prachex T., Meyer M., Démonet J.F., Rouaud O., 2020/10. Multiple sclerosis and related disorders, 45 p. 102349. Peer-reviewed.
 
Tele-neuropsychology, older patients and Covid-19 pandemic
Genoud-Prachex Thomas, Perrenoud Matthieu Paul, Brioschi Guevara andrea, Moser Charlène, Bieler-Aeschlimann Mélanie, Rouaud Olivier, Démonet jean-François, 2020/04/01. Revue de neuropsychologie.
 
High Prevalence of Social Cognition Disorders and Mild Cognitive Impairment Long Term After Stroke.
Sensenbrenner B., Rouaud O., Graule-Petot A., Guillemin S., Piver A., Giroud M., Béjot Y., Jacquin-Piques A., 2020. Alzheimer disease and associated disorders, 34 (1) pp. 72-78. Peer-reviewed.
In the here and now: Short term memory predictions are preserved in Alzheimer's disease.
Bertrand J.M., Mazancieux A., Moulin CJA, Béjot Y., Rouaud O., Souchay C., 2019/10. Cortex; a journal devoted to the study of the nervous system and behavior, 119 pp. 158-164. Peer-reviewed.
 
How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years.
Epelbaum S., Paquet C., Hugon J., Dumurgier J., Wallon D., Hannequin D., Jonveaux T., Besozzi A., Pouponneau S., Hommet C. et al., 2019/06/24. BMJ open, 9 (6) pp. e029663. Peer-reviewed.
 
Actualités dans les domaines du diagnostic et de la recherche en Suisse sur la maladie d’Alzheimer
Rouaud Olivier, Brioschi Guevara Andrea, Damian Daniel, Frisoni Giovanni, Démonet Jean-François, 2019. Gérontologie appliquée.
 
Causative Mutations and Genetic Risk Factors in Sporadic Early Onset Alzheimer's Disease Before 51 Years.
Lacour M., Quenez O., Rovelet-Lecrux A., Salomon B., Rousseau S., Richard A.C., Quillard-Muraine M., Pasquier F., Rollin-Sillaire A., Martinaud O. et al., 2019. Journal of Alzheimer's disease, 71 (1) pp. 227-243. Peer-reviewed.
 
Lipid Biomarkers in Alzheimer's Disease.
Zarrouk A., Debbabi M., Bezine M., Karym E.M., Badreddine A., Rouaud O., Moreau T., Cherkaoui-Malki M., El Ayeb M., Nasser B. et al., 2018/02/22. Current Alzheimer research, 15 (4) pp. 303-312. Peer-reviewed.
 
Evaluation de la mémoire prospective chez des patients-e-s se présentant dans un Centre mémoire universitaire
Chatton Pauline, Rouaud Olivier, Démonet Jean-François, Brioschi Guevara Andrea, 2018. dans 11ème congrès international francophone de gérontologie et gériatrie. .
 
Memory center: The Lausanne model
Damian Daniel, Rouaud Olivier, Draganski Bogdan, Brioschi Guevara Andrea, Bortolotti Murielle, Laouadi Marie-Hélène, Démonet Jean-François, 2018. Clinical and translational Neuroscience.
Neural correlates of episodic memory in the Memento cohort.
Epelbaum S., Bouteloup V., Mangin J.F., La Corte V., Migliaccio R., Bertin H., Habert M.O., Fischer C., Azouani C., Fillon L. et al., 2018. Alzheimer's & dementia, 4 pp. 224-233. Peer-reviewed.
Temporal trends in the premorbid use of preventive treatments in patients with acute ischemic cerebrovascular events and a history of vascular disease: The Dijon Stroke Registry (1985-2010).
Khoumri C., Bailly H., Delpont B., Daubail B., Blanc C., Chazalon C., Durier J., Hervieu-Bègue M., Osseby G.V., Rouaud O. et al., 2017/12. Presse medicale, 46 (12 Pt 1) pp. e259-e267. Peer-reviewed.
Gender effect on driving cessation in pre-dementia and dementia phases: results of the 3C population-based study.
Marie Dit Asse L., Fabrigoule C., Helmer C., Laumon B., Berr C., Rouaud O., Auriacombe S., Lafont S., 2017/10. International journal of geriatric psychiatry, 32 (10) pp. 1049-1058. Peer-reviewed.
Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort.
Dufouil C., Dubois B., Vellas B., Pasquier F., Blanc F., Hugon J., Hanon O., Dartigues J.F., Harston S., Gabelle A. et al., 2017/08/29. Alzheimer's research & therapy, 9 (1) p. 67. Peer-reviewed.
Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
Andrieu S., Guyonnet S., Coley N., Cantet C., Bonnefoy M., Bordes S., Bories L., Cufi M.N., Dantoine T., Dartigues J.F. et al., 2017/05. The Lancet. Neurology, 16 (5) pp. 377-389. Peer-reviewed.
Gait Speed and Decline in Gait Speed as Predictors of Incident Dementia.
Dumurgier J., Artaud F., Touraine C., Rouaud O., Tavernier B., Dufouil C., Singh-Manoux A., Tzourio C., Elbaz A., 2017/05/01. The journals of gerontology. Series A, Biological sciences and medical sciences, 72 (5) pp. 655-661. Peer-reviewed.
Temporal trends in early case-fatality rates in patients with intracerebral hemorrhage.
Béjot Y., Grelat M., Delpont B., Durier J., Rouaud O., Osseby G.V., Hervieu-Bègue M., Giroud M., Cordonnier C., 2017/03/07. Neurology, 88 (10) pp. 985-990. Peer-reviewed.
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
Lanoiselée H.M., Nicolas G., Wallon D., Rovelet-Lecrux A., Lacour M., Rousseau S., Richard A.C., Pasquier F., Rollin-Sillaire A., Martinaud O. et al., 2017/03. PLoS medicine, 14 (3) pp. e1002270. Peer-reviewed.
 
Effectiveness of a Standardized and Specific Follow-Up in Memory Centers in Patients with Alzheimer's Disease.
Rouch L., Cestac P., Cool C., Helmer C., Dartigues J.F., Berr C., Rouaud O., Vellas B., Andrieu S., REAL-FR Study Group and the 3C Study Group, 2017. Current Alzheimer research, 14 (3) pp. 255-267. Peer-reviewed.
 
Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease.
Cavedo E., Dubois B., Colliot O., Lista S., Croisile B., Tisserand G.L., Touchon J., Bonafe A., Ousset P.J., Rouaud O. et al., 2016/12. The Journal of clinical psychiatry, 77 (12) pp. e1631-e1638. Peer-reviewed.
Vitamin K Antagonists and Cognitive Function in Older Adults: The Three-City Cohort Study.
Ferland G., Feart C., Presse N., Lorrain S., Bazin F., Helmer C., Berr C., Annweiler C., Rouaud O., Dartigues J.F. et al., 2016/10. The journals of gerontology. Series A, Biological sciences and medical sciences, 71 (10) pp. 1356-1362. Peer-reviewed.
 
Telemedicine for the acute management of stroke in Burgundy, France: an evaluation of effectiveness and safety.
Legris N., Hervieu-Bègue M., Daubail B., Daumas A., Delpont B., Osseby G.V., Rouaud O., Giroud M., Béjot Y., 2016/09. European journal of neurology, 23 (9) pp. 1433-1440. Peer-reviewed.
ADL disability and death in dementia in a French population-based cohort: New insights with an illness-death model.
Delva F., Touraine C., Joly P., Edjolo A., Amieva H., Berr C., Rouaud O., Helmer C., Pérès K., Dartigues J.F., 2016/08. Alzheimer's & dementia, 12 (8) pp. 909-916. Peer-reviewed.
 
Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home.
Jacquin-Piques A., Sacco G., Tavassoli N., Rouaud O., Bejot Y., Giroud M., Robert P., Vellas B., Bonin-Guillaume S., 2016. Journal of Alzheimer's disease, 49 (3) pp. 671-680. Peer-reviewed.
Semantic memory assessment in 15 patients with amyotrophic lateral sclerosis.
Hervieu-Bègue M., Rouaud O., Graule Petot A., Catteau A., Giroud M., 2016. Revue neurologique, 172 (4-5) pp. 307-312. Peer-reviewed.
The Clock'N Test as a Possible Measure of Emotions: Normative Data Collected on a Non-clinical Population.
Gros A., Manera V., Daumas A., Guillemin S., Rouaud O., Martin M.L., Giroud M., Béjot Y., 2016. Frontiers in behavioral neuroscience, 10 p. 8. Peer-reviewed.
The Early Indicators of Functional Decrease in Mild Cognitive Impairment.
Kubicki A., Fautrelle L., Bourrelier J., Rouaud O., Mourey F., 2016. Frontiers in aging neuroscience, 8 p. 193. Peer-reviewed.
 
Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease.
Dubois B., Chupin M., Hampel H., Lista S., Cavedo E., Croisile B., Louis Tisserand G., Touchon J., Bonafe A., Ousset P.J. et al., 2015/09. Alzheimer's & dementia, 11 (9) pp. 1041-1049. Peer-reviewed.
Elderly benzodiazepine users at increased risk of activity limitations: influence of chronicity, indications, and duration of action--the three-city cohort.
Carrière I., Mura T., Pérès K., Norton J., Jaussent I., Edjolo A., Rouaud O., Berr C., Ritchie K., Ancelin M.L., 2015/08. The American journal of geriatric psychiatry, 23 (8) pp. 840-851. Peer-reviewed.
Alzheimer's disease associated with sporadic cerebral amyloid angiopathy in an elderly patient.
Guaquière-Bernard O., Rouaud O., Manckoundia P., 2015/06. Geriatrics & gerontology international, 15 (6) pp. 811-812. Peer-reviewed.
Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderly.
Gabelle A., Schraen S., Gutierrez L.A., Pays C., Rouaud O., Buée L., Touchon J., Helmer C., Lambert J.C., Berr C., 2015/06. Alzheimer's & dementia, 11 (6) pp. 672-680. Peer-reviewed.
Carotid plaque as a predictor of dementia in older adults: the Three-City Study.
Carcaillon L., Plichart M., Zureik M., Rouaud O., Majed B., Ritchie K., Tzourio C., Dartigues J.F., Empana J.P., 2015/03. Alzheimer's & dementia, 11 (3) pp. 239-248. Peer-reviewed.
Dual effect of docosahexaenoic acid (attenuation or amplification) on C22:0-, C24:0-, and C26:0-induced mitochondrial dysfunctions and oxidative stress on human neuronal SK-N-BE cells.
Zarrouk A., Nury T., Riedinger J.M., Rouaud O., Hammami M., Lizard G., 2015/02. The journal of nutrition, health & aging, 19 (2) pp. 198-205. Peer-reviewed.
A time estimation task as a possible measure of emotions: difference depending on the nature of the stimulus used.
Gros A., Giroud M., Bejot Y., Rouaud O., Guillemin S., Aboa Eboulé C., Manera V., Daumas A., Lemesle Martin M., 2015. Frontiers in behavioral neuroscience, 9 p. 143. Peer-reviewed.
Diagnostic procedures in ischaemic stroke patients with dementia. a population-based study.
Béjot Y., Jacquin A., Troisgros O., Rouaud O., Aboa-Eboulé C., Hervieu M., Osseby G.V., Giroud M., 2015/01. International journal of stroke, 10 (1) pp. 95-98. Peer-reviewed.
 
Fatty acid profiles in demented patients: identification of hexacosanoic acid (C26:0) as a blood lipid biomarker of dementia.
Zarrouk A., Riedinger J.M., Ahmed S.H., Hammami S., Chaabane W., Debbabi M., Ben Ammou S., Rouaud O., Frih M., Lizard G. et al., 2015. Journal of Alzheimer's disease, 44 (4) pp. 1349-1359. Peer-reviewed.
Mental Rotation as an Indicator of Motor Representation in Patients with Mild Cognitive Impairment.
Bourrelier J., Kubicki A., Rouaud O., Crognier L., Mourey F., 2015. Frontiers in aging neuroscience, 7 p. 238. Peer-reviewed.
Impact of a premature menopause on cognitive function in later life.
Ryan J., Scali J., Carrière I., Amieva H., Rouaud O., Berr C., Ritchie K., Ancelin M.L., 2014/12. BJOG, 121 (13) pp. 1729-1739. Peer-reviewed.
Factors associated with early recurrence at the first evaluation of patients with transient ischemic attack.
Daubail B., Durier J., Jacquin A., Hervieu-Bègue M., Khoumri C., Osseby G.V., Rouaud O., Giroud M., Béjot Y., 2014/11. Journal of clinical neuroscience, 21 (11) pp. 1940-1944. Peer-reviewed.
A de novo nonsense PDGFB mutation causing idiopathic basal ganglia calcification with laryngeal dystonia.
Nicolas G., Jacquin A., Thauvin-Robinet C., Rovelet-Lecrux A., Rouaud O., Pottier C., Aubriot-Lorton M.H., Rousseau S., Wallon D., Duvillard C. et al., 2014/10. European journal of human genetics, 22 (10) pp. 1236-1238. Peer-reviewed.
Impact of harmonization of collection tubes on Alzheimer's disease diagnosis.
Lehmann S., Schraen S., Quadrio I., Paquet C., Bombois S., Delaby C., Dorey A., Dumurgier J., Hirtz C., Krolak-Salmon P. et al., 2014/10. Alzheimer's & dementia, 10 (5 Suppl) pp. S390-S394.e2. Peer-reviewed.
Gender-specific associations between lipids and cognitive decline in the elderly.
Ancelin M.L., Ripoche E., Dupuy A.M., Samieri C., Rouaud O., Berr C., Carrière I., Ritchie K., 2014/07. European neuropsychopharmacology, 24 (7) pp. 1056-1066. Peer-reviewed.
MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER'S DISEASE: DESIGN AND BASELINE DATA.
Vellas B., Carrie I., Gillette-Guyonnet S., Touchon J., Dantoine T., Dartigues J.F., Cuffi M.N., Bordes S., Gasnier Y., Robert P. et al., 2014/06. The journal of prevention of Alzheimer's disease, 1 (1) pp. 13-22. Peer-reviewed.
Trends in the incidence of ischaemic stroke in young adults between 1985 and 2011: the Dijon Stroke Registry.
Béjot Y., Daubail B., Jacquin A., Durier J., Osseby G.V., Rouaud O., Giroud M., 2014/05. Journal of neurology, neurosurgery, and psychiatry, 85 (5) pp. 509-513. Peer-reviewed.
The association between caffeine and cognitive decline: examining alternative causal hypotheses.
Ritchie K., Ancelin M.L., Amieva H., Rouaud O., Carrière I., 2014/04. International psychogeriatrics, 26 (4) pp. 581-590. Peer-reviewed.
The impact of World and European Football Cups on stroke in the population of Dijon, France: a longitudinal study from 1986 to 2006.
Aboa-Eboulé C., Béjot Y., Cottenet J., Khellaf M., Jacquin A., Durier J., Rouaud O., Hervieu-Begue M., Osseby G.V., Giroud M. et al., 2014/03. Journal of stroke and cerebrovascular diseases, 23 (3) pp. e229-35. Peer-reviewed.
High plasma estradiol interacts with diabetes on risk of dementia in older postmenopausal women.
Carcaillon L., Brailly-Tabard S., Ancelin M.L., Rouaud O., Dartigues J.F., Guiochon-Mantel A., Scarabin P.Y., 2014/02/11. Neurology, 82 (6) pp. 504-511. Peer-reviewed.
Estrogen receptor polymorphisms and incident dementia: the prospective 3C study.
Ryan J., Carrière I., Carcaillon L., Dartigues J.F., Auriacombe S., Rouaud O., Berr C., Ritchie K., Scarabin P.Y., Ancelin M.L., 2014/01. Alzheimer's & dementia, 10 (1) pp. 27-35. Peer-reviewed.
 
Post-stroke cognitive impairment: high prevalence and determining factors in a cohort of mild stroke.
Jacquin A., Binquet C., Rouaud O., Graule-Petot A., Daubail B., Osseby G.V., Bonithon-Kopp C., Giroud M., Béjot Y., 2014. Journal of Alzheimer's disease, 40 (4) pp. 1029-1038. Peer-reviewed.
Vascular aphasia outcome after intravenous recombinant tissue plasminogen activator thrombolysis for ischemic stroke.
Jacquin A., Virat-Brassaud M.E., Rouaud O., Osseby G.V., Aboa-Eboulé C., Hervieu M., Ménassa M., Ricolfi F., Giroud M., Béjot Y., 2014. European neurology, 71 (5-6) pp. 288-295. Peer-reviewed.
Prospective analysis of the association between estrogen receptor gene variants and the risk of cognitive decline in elderly women.
Ryan J., Carrière I., Amieva H., Rouaud O., Berr C., Ritchie K., Scarabin P.Y., Ancelin M.L., 2013/12. European neuropsychopharmacology, 23 (12) pp. 1763-1768. Peer-reviewed.
Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification.
Nicolas G., Pottier C., Charbonnier C., Guyant-Maréchal L., Le Ber I., Pariente J., Labauge P., Ayrignac X., Defebvre L., Maltête D. et al., 2013/11. Brain, 136 (Pt 11) pp. 3395-3407. Peer-reviewed.
A J-shaped association between plasma testosterone and risk of ischemic arterial event in elderly men: the French 3C cohort study.
Soisson V., Brailly-Tabard S., Helmer C., Rouaud O., Ancelin M.L., Zerhouni C., Guiochon-Mantel A., Scarabin P.Y., 2013/07. Maturitas, 75 (3) pp. 282-288. Peer-reviewed.
Prestroke antiplatelet therapy and early prognosis in stroke patients: the Dijon Stroke Registry.
Béjot Y., Aboa-Eboulé C., de Maistre E., Jacquin A., Troisgros O., Hervieu M., Osseby G.V., Rouaud O., Giroud M., 2013/06. European journal of neurology, 20 (6) pp. 879-890. Peer-reviewed.
Intracerebral haemorrhage profiles are changing: results from the Dijon population-based study.
Béjot Y., Cordonnier C., Durier J., Aboa-Eboulé C., Rouaud O., Giroud M., 2013/02. Brain, 136 (Pt 2) pp. 658-664. Peer-reviewed.
 
Plasma amyloid-β levels and prognosis in incident dementia cases of the 3-City Study.
Gabelle A., Richard F., Gutierrez L.A., Schraen S., Delva F., Rouaud O., Buée L., Dartigues J.F., Touchon J., Lambert J.C. et al., 2013. Journal of Alzheimer's disease, 33 (2) pp. 381-391. Peer-reviewed.
Psychiatric Presentation of Frontotemporal Dementia Associated with Inclusion Body Myopathy due to the VCP Mutation (R155H) in a French Family.
Jacquin A., Rouaud O., Soichot P., Bejot Y., Dygai-Cochet I., Sarazin M., Stojkovic T., Lemesle-Martin M., Giroud M., Moreau T., 2013. Case reports in neurology, 5 (3) pp. 187-194. Peer-reviewed.
 
Serum 25-hydroxyvitamin D predicts severity and prognosis in stroke patients.
Daubail B., Jacquin A., Guilland J.C., Hervieu M., Osseby G.V., Rouaud O., Giroud M., Béjot Y., 2013/01. European journal of neurology, 20 (1) pp. 57-61. Peer-reviewed.
 
Sex differences in the associations between lipid levels and incident dementia.
Ancelin M.L., Ripoche E., Dupuy A.M., Barberger-Gateau P., Auriacombe S., Rouaud O., Berr C., Carrière I., Ritchie K., 2013. Journal of Alzheimer's disease, 34 (2) pp. 519-528. Peer-reviewed.
 
Endogenous oestradiol as a positive correlate of plasma fibrinogen among older postmenopausal women: a population-based study (the Three-City cohort study).
Canonico M., Brailly-Tabard S., Gaussem P., Setiao J., Rouaud O., Ryan J., Carcaillon L., Guiochon-Mantel A., Scarabin P.Y., 2012/12. Clinical endocrinology, 77 (6) pp. 905-910. Peer-reviewed.
 
Epidémiologie des accidents vasculaires cérébraux du sujet âgé : "The silver tsunami" [Epidemiology of stroke in the elderly : "the silver tsunami"]
Jacquin A., Hervieu-Bègue M., Daubail B., Osseby G.V., Rouaud O., Giroud M., Béjot Y., 2012/11. La Revue du praticien, 62 (9) pp. 1221-1224. Peer-reviewed.
 
Is frailty a prodromal stage of vascular dementia? Results from the Three-City Study.
Avila-Funes J.A., Carcaillon L., Helmer C., Carrière I., Ritchie K., Rouaud O., Tzourio C., Dartigues J.F., Amieva H., 2012/09. Journal of the American Geriatrics Society, 60 (9) pp. 1708-1712. Peer-reviewed.
Steroid and nonsteroidal anti-inflammatory drugs, cognitive decline, and dementia.
Ancelin M.L., Carrière I., Helmer C., Rouaud O., Pasquier F., Berr C., Chaudieu I., Ritchie K., 2012/09. Neurobiology of aging, 33 (9) pp. 2082-2090. Peer-reviewed.
The STAI-Y trait scale: psychometric properties and normative data from a large population-based study of elderly people.
Bergua V., Meillon C., Potvin O., Bouisson J., Le Goff M., Rouaud O., Ritchie K., Dartigues J.F., Amieva H., 2012/07. International psychogeriatrics, 24 (7) pp. 1163-1171. Peer-reviewed.
 
One-year survival of demented stroke patients: data from the Dijon Stroke Registry, France (1985-2008).
Béjot Y., Jacquin A., Rouaud O., Durier J., Aboa-Eboulé C., Hervieu M., Osseby G.V., Giroud M., 2012/05. European journal of neurology, 19 (5) pp. 712-717. Peer-reviewed.
Recruitment strategies for preventive trials. The MAPT study (MultiDomain Alzheimer Preventive Trial).
Carrié I., van Kan G.A., Gillette-Guyonnet S., Andrieu S., Dartigues J.F., Touchon J., Dantoine T., Rouaud O., Bonnefoy M., Robert P. et al., 2012/04. The journal of nutrition, health & aging, 16 (4) pp. 355-359. Peer-reviewed.
Estrogen receptor alpha gene variants and major depressive episodes.
Ryan J., Scali J., Carrière I., Peres K., Rouaud O., Scarabin P.Y., Ritchie K., Ancelin M.L., 2012/02. Journal of affective disorders, 136 (3) pp. 1222-1226. Peer-reviewed.
Factors associated with caregivers' underestimation of quality of life in patients with Alzheimer's disease.
Zhao H., Novella J.L., Dramé M., Mahmoudi R., Barbe C., di Pollina L., Aquino J.P., Pfitzenmeyer P., Rouaud O., George M.Y. et al., 2012. Dementia and geriatric cognitive disorders, 33 (1) pp. 11-17. Peer-reviewed.
 
Lipid lowering agents, cognitive decline, and dementia: the three-city study.
Ancelin M.L., Carrière I., Barberger-Gateau P., Auriacombe S., Rouaud O., Fourlanos S., Berr C., Dupuy A.M., Ritchie K., 2012. Journal of Alzheimer's disease, 30 (3) pp. 629-637. Peer-reviewed.
 
Potential roles of peroxisomes in Alzheimer's disease and in dementia of the Alzheimer's type.
Lizard G., Rouaud O., Demarquoy J., Cherkaoui-Malki M., Iuliano L., 2012. Journal of Alzheimer's disease, 29 (2) pp. 241-254. Peer-reviewed.
Prior transient ischemic attack and dementia after subsequent ischemic stroke.
Jacquin A., Aboa-Eboulé C., Rouaud O., Osseby G.V., Binquet C., Durier J., Moreau T., Bonithon-Kopp C., Giroud M., Béjot Y., 2012. Alzheimer disease and associated disorders, 26 (4) pp. 307-313. Peer-reviewed.
Should we consider the depth of the cortex for the use of rTMS?
Trojak B., Meille V., Rouaud O., Chauvet-Gelinier J.C., Bonin B., 2012. The Journal of neuropsychiatry and clinical neurosciences, 24 (2) pp. E3-4. Peer-reviewed.
The deleterious effect of admission hyperglycemia on survival and functional outcome in patients with intracerebral hemorrhage.
Béjot Y., Aboa-Eboulé C., Hervieu M., Jacquin A., Osseby G.V., Rouaud O., Giroud M., 2012/01. Stroke, 43 (1) pp. 243-245. Peer-reviewed.
Influence of prior transient ischaemic attack on stroke prognosis.
Aboa-Eboulé C., Béjot Y., Osseby G.V., Rouaud O., Binquet C., Marie C., Cottin Y., Giroud M., Bonithon-Kopp C., 2011/09. Journal of neurology, neurosurgery, and psychiatry, 82 (9) pp. 993-1000. Peer-reviewed.
Oestrogen receptor polymorphisms and late-life depression.
Ryan J., Scali J., Carrière I., Peres K., Rouaud O., Scarabin P.Y., Ritchie K., Ancelin M.L., 2011/08. The British journal of psychiatry, 199 (2) pp. 126-131. Peer-reviewed.
CSF biomarkers in posterior cortical atrophy.
Seguin J., Formaglio M., Perret-Liaudet A., Quadrio I., Tholance Y., Rouaud O., Thomas-Anterion C., Croisile B., Mollion H., Moreaud O. et al., 2011/05/24. Neurology, 76 (21) pp. 1782-1788. Peer-reviewed.
Prevalence of early dementia after first-ever stroke: a 24-year population-based study.
Béjot Y., Aboa-Eboulé C., Durier J., Rouaud O., Jacquin A., Ponavoy E., Richard D., Moreau T., Giroud M., 2011/03. Stroke, 42 (3) pp. 607-612. Peer-reviewed.
Association study of the CFH Y402H polymorphism with Alzheimer's disease.
Le Fur I., Laumet G., Richard F., Fievet N., Berr C., Rouaud O., Delcourt C., Amouyel P., Lambert J.C., 2010/01. Neurobiology of aging, 31 (1) pp. 165-166. Peer-reviewed.
 
Joint effect of white matter lesions and hippocampal volumes on severity of cognitive decline: the 3C-Dijon MRI study.
Godin O., Tzourio C., Rouaud O., Zhu Y., Maillard P., Pasquier F., Crivello F., Alpérovitch A., Mazoyer B., Dufouil C., 2010. Journal of Alzheimer's disease, 20 (2) pp. 453-463. Peer-reviewed.
Stroke in the very old: incidence, risk factors, clinical features, outcomes and access to resources--a 22-year population-based study.
Béjot Y., Rouaud O., Jacquin A., Osseby G.V., Durier J., Manckoundia P., Pfitzenmeyer P., Moreau T., Giroud M., 2010/01. Cerebrovascular diseases, 29 (2) pp. 111-121. Peer-reviewed.
Transient ischaemic attack mimics revealing focal subarachnoid haemorrhage.
Brunot S., Osseby G.V., Rouaud O., Kazemi A., Ricolfi F., Couvreur G., Catteau A., Hervieu M., Moreau T., Giroud M. et al., 2010. Cerebrovascular diseases, 30 (6) pp. 597-601. Peer-reviewed.
Utilisation des antidépresseurs chez les sujets âgés déments: données actuelles [Antidepressant use in demented elderly subjects: current data]
Bélicard-Pernot C., Manckoundia P., Ponavoy E., Rouaud O., Pfitzenmeyer P., 2009/11. La Revue de medecine interne, 30 (11) pp. 947-954. Peer-reviewed.
Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study.
Lambert J.C., Schraen-Maschke S., Richard F., Fievet N., Rouaud O., Berr C., Dartigues J.F., Tzourio C., Alpérovitch A., Buée L. et al., 2009/09/15. Neurology, 73 (11) pp. 847-853. Peer-reviewed.
Leisure activities and the risk of dementia in the elderly: results from the Three-City Study.
Akbaraly T.N., Portet F., Fustinoni S., Dartigues J.F., Artero S., Rouaud O., Touchon J., Ritchie K., Berr C., 2009/09/15. Neurology, 73 (11) pp. 854-861. Peer-reviewed.
 
Faut-il réaliser un "Mini-Mental State Examination" chez tout sujet âgé hypertendu? [Should all old hypertensive subjects have Mini-Mental State Examination?]
Manckoundia P., Marilier S., Mazen E., Perret-Guillaume C., Rouaud O., Mahmoudi R., Joly L., Bénétos A., Pfitzenmeyer P., 2009/09. Journal des maladies vasculaires, 34 (4) pp. 253-263. Peer-reviewed.
Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.
Carrière I., Fourrier-Reglat A., Dartigues J.F., Rouaud O., Pasquier F., Ritchie K., Ancelin M.L., 2009/07/27. Archives of internal medicine, 169 (14) pp. 1317-1324. Peer-reviewed.
 
Changes in risk factors and preventive treatments by stroke subtypes over 20 years: a population-based study
Bejot Y., Osseby G. V., Gremeaux V., Durier J., Rouaud O., Moreau T., Giroud M., 2009. J Neurol Sci, 287 (1-2) pp. 84-8.
Les accidents vasculaires cérébraux : ce qui a changé au début du xxi(e) siècle [What has changed for stroke at the beginning of the 21st century]
Bejot Y., Gentil A., Biotti D., Rouaud O., Fromont A., Couvreur G., Benatru I., Osseby G.V., Moreau T., Giroud M., 2009. Revue neurologique, 165 (8-9) pp. 617-625. Peer-reviewed.
Ischaemic stroke subtypes and associated risk factors: a French population based study.
Bejot Y., Caillier M., Ben Salem D., Couvreur G., Rouaud O., Osseby G.V., Durier J., Marie C., Moreau T., Giroud M., 2008/12. Journal of neurology, neurosurgery, and psychiatry, 79 (12) pp. 1344-1348. Peer-reviewed.
Les accidents vasculaires cérébraux du sujet âgé : ce que nous a appris l'épidémiologie du sujet jeune [Stroke in elderly: what have we learned from stroke epidemiology in younger people]
Bejot Y., Rouaud O., Gentil A., Caillier M., Manckoundia P., Pfitzenmeyer P., Osseby G.V., Moreau T., Giroud M., 2008/10. Revue neurologique, 164 (10) pp. 809-814. Peer-reviewed.
 
N-acetylaspartate/creatine and choline/creatine ratios in the thalami, insular cortex and white matter as markers of hypertension and cognitive impairment in the elderly.
Ben Salem D., Walker P.M., Bejot Y., Aho S.L., Tavernier B., Rouaud O., Ricolfi F., Brunotte F., 2008/10. Hypertension research, 31 (10) pp. 1851-1857. Peer-reviewed.
Syndrome démentiel du sujet âgé lié à un traitement par acide valproïque: à propos d'un cas [Dementia syndrome in an elderly subject related to valproic acid use: a case report]
Manckoundia P., Disson-Dautriche A., Rouaud O., Richard D., Tavernier-Vidal B., Pfitzenmeyer P., 2008/10. La Revue de medecine interne, 29 (10) pp. 827-829. Peer-reviewed.
Risk profiles for mild cognitive impairment and progression to dementia are gender specific.
Artero S., Ancelin M.L., Portet F., Dupuy A., Berr C., Dartigues J.F., Tzourio C., Rouaud O., Poncet M., Pasquier F. et al., 2008/09. Journal of neurology, neurosurgery, and psychiatry, 79 (9) pp. 979-984. Peer-reviewed.
Trends in incidence, risk factors, and survival in symptomatic lacunar stroke in Dijon, France, from 1989 to 2006: a population-based study.
Bejot Y., Catteau A., Caillier M., Rouaud O., Durier J., Marie C., Di Carlo A., Osseby G.V., Moreau T., Giroud M., 2008/07. Stroke, 39 (7) pp. 1945-1951. Peer-reviewed.
Le botulisme est toujours d'actualité [Botulism has not disappeared]
Gentil A., Soichot P., Maugras C., Lemesle-Martin M., Béjot Y., Rouaud O., Osseby G.V., Fromont A., Couvreur G., Moreau T. et al., 2008/05. Presse medicale, 37 (5 Pt 1) pp. 789-792. Peer-reviewed.
Démence sémantique: réflexions d'un groupe de travail pour des critères de diagnostic en français et la constitution d'une cohorte de patients [Semantic dementia: reflexions of a French working group for diagnostic criteria and constitution of a patient cohort]
Moreaud O., Belliard S., Snowden J., Auriacombe S., Basaglia-Pappas S., Bernard F., Bon L., Boutantin J., Boutoleau-Bretonnière C., Charnallet A. et al., 2008/04. Revue neurologique, 164 (4) pp. 343-353. Peer-reviewed.
Les apports du registre dijonnais des accidents vasculaires cérébraux en 20 ans d'activité [Contribution of the Dijon Stroke Registry after 20 years of data collection]
Bejot Y., Rouaud O., Benatru I., Fromont A., Couvreur G., Caillier M., Gentil A., Osseby G.V., Lemesle M., Decavel P. et al., 2008/02. Revue neurologique, 164 (2) pp. 138-147. Peer-reviewed.
Primary and secondary care consultations in elderly demented individuals in France. Results from the Three-City Study.
Helmer C., Pérès K., Pariente A., Pasquier F., Auriacombe S., Poncet M., Portet F., Rouaud O., Ritchie K., Tzourio C. et al., 2008. Dementia and geriatric cognitive disorders, 26 (5) pp. 407-415. Peer-reviewed.
Epidemiology of stroke in Europe: geographic and environmental differences.
Bejot Y., Benatru I., Rouaud O., Fromont A., Besancenot J.P., Moreau T., Giroud M., 2007/11/15. Journal of the neurological sciences, 262 (1-2) pp. 85-88. Peer-reviewed.
The neuroprotective effects of caffeine: a prospective population study (the Three City Study).
Ritchie K., Carrière I., de Mendonca A., Portet F., Dartigues J.F., Rouaud O., Barberger-Gateau P., Ancelin M.L., 2007/08/07. Neurology, 69 (6) pp. 536-545. Peer-reviewed.
Troubles bipolaires et démence: association fortuite ou filiation? [Bipolar disorders and dementia: fortuitous association or filiation? A case-report and review of the literature]
Menecier P., Rouaud O., Arezes C., Nasr D., Menecier-Ossia L., Charvet-Blanc A., Ploton L., 2007/03. Psychologie & neuropsychiatrie du vieillissement, 5 (1) pp. 23-34. Peer-reviewed.
 
Evolution sur vingt ans des taux d'incidence et de mortalité des AVC au sein de la population de dijon intra-muros: 1985-2004 [Trends in stroke incidence and case-fatality rates over a 20-year period (1985-2004) in Dijon, France]
Bejot Y., Giroud M., Rouaud O., Benatru I., Moreau T., Freycz M., Osseby G.V., Neurologues Hospitaliers et Libéraux de Dijon, 2007/02. Bulletin de l'Academie nationale de medecine, 191 (2) pp. 305-22; discussion 322-4. Peer-reviewed.
Decrease in the stroke case fatality rates in a French population-based twenty-year study. A comparison between men and women.
Bejot Y., Rouaud O., Durier J., Caillier M., Marie C., Freysz M., Yeguiayan J.M., Chantegret A., Osseby G., Moreau T. et al., 2007. Cerebrovascular diseases, 24 (5) pp. 439-444. Peer-reviewed.
Epidémiologie des accidents vasculaires cérébraux. Impacts sur la décision thérapeutique [Epidemiology of strokes. Impact on the treatment decision]
Bejot Y., Caillier M., Rouaud O., Benatru I., Maugras C., Osseby G.V., Giroud M., 2007/01. Presse medicale, 36 (1 Pt 2) pp. 117-127. Peer-reviewed.
Trends in the incidence of transient ischemic attacks, premorbid risk factors and the use of preventive treatments in the population of Dijon, France from 1985 to 2004.
Bejot Y., Rouaud O., Benatru I., Durier J., Caillier M., Couvreur G., Fromont A., Falvo N., Osseby G.V., Cottin Y. et al., 2007. Cerebrovascular diseases, 23 (2-3) pp. 126-131. Peer-reviewed.
 
Dépression après un accident vasculaire cérébral, un handicap supplémentaire [Post-stroke depression, another handicap]
Pinoit J.M., Bejot Y., Rouaud O., Benatru I., Osseby G.V., Bonin B., Gisselmann A., Giroud M., 2006/12. Presse medicale, 35 (12 Pt 1) pp. 1789-1793. Peer-reviewed.
 
Apport de l'évaluation écologique des troubles exécutifs dans la sclérose en plaques [Contribution of ecological evaluation of executive disorders in multiple sclerosis]
Rouaud O., Graule-Petot A., Couvreur G., Contegal F., Osseby G.V., Benatru I., Giroud M., Moreau T., 2006/10. Revue neurologique, 162 (10) pp. 964-969. Peer-reviewed.
Stable stroke incidence rates but improved case-fatality in Dijon, France, from 1985 to 2004.
Benatru I., Rouaud O., Durier J., Contegal F., Couvreur G., Bejot Y., Osseby G.V., Ben Salem D., Ricolfi F., Moreau T. et al., 2006/07. Stroke, 37 (7) pp. 1674-1679. Peer-reviewed.
Consultation après un infarctus ou un hématome cérébral [Consultation after cerebral infarction or intracerebral hematoma]
Benatru I., Contegal F., Rouaud O., Caillier M., Menassa M., Osseby G.V., Vernet B., Durier J., Fromont A., Moreau T. et al., 2006/01. Presse medicale, 35 (1 Pt 2) pp. 97-104. Peer-reviewed.
Particularités de l'accident vasculaire cérébral du sujet âgé et impact sur la prise en charge [Specificity of stroke in the elderly: clinical characteristics and impact on care]
Rouaud O., Contegal F., Benatru I., Couvreur G., Osseby G.V., Pinoit J.M., Terriat B., Moreau T., Pfitzenmeyer P., Giroud M., 2005/09. Psychologie & neuropsychiatrie du vieillissement, 3 (3) pp. 147-155. Peer-reviewed.
 
Le syndrome de la main étrangère par infarctus du corps calleux. A propos d'un cas [Alien hand syndrome due to a corpus callosum infarct: a case report]
Billard T., Osseby G.V., Minier D., Couvreur G., Rouaud O., Moreau T., Giroud M., 2004/05. Revue neurologique, 160 (5 Pt 1) pp. 563-567. Peer-reviewed.
Spectroscopic data following stroke reveal tissue abnormality beyond the region of T2-weighted hyperintensity.
Demougeot C., Walker P., Beley A., Marie C., Rouaud O., Giroud M., Brunotte F., 2002/07/15. Journal of the neurological sciences, 199 (1-2) pp. 73-78. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University